| NDC Code | 70842-140-03 |
|---|
| Package Description | 3 VIAL, GLASS in 1 CARTON (70842-140-03) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (70842-140-01) |
|---|
| Product NDC | 70842-140 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Orbactiv |
|---|
| Non-Proprietary Name | Oritavancin |
|---|
| Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
|---|
| Usage | INTRAVENOUS |
|---|
| Start Marketing Date | 20140901 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA206334 |
|---|
| Manufacturer | Melinta Therapeutics, LLC |
|---|
| Substance Name | ORITAVANCIN |
|---|
| Strength | 400 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C9 Inhibitors [MoA], Cytochrome P450 2D6 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Lipoglycopeptide Antibacterial [EPC], Lipoglycopeptides [CS] |
|---|